Pimasertib
Drug timelines are a Plus or Pro feature.
10 regulatory and trial events tracked for Pimasertib, covering 2016-02-25 to 2026-03-18. Get the full timeline:
Most recent: Clinical Trial Update: Bintrafusp Alfa and Pimasertib for the Treatment of Patients With Brain Metastases [Phase 1, Phase 2]